Our pilot study showed a significant elevation in IgE levels (a product of allergic reaction) in e-cigarette users compared to non-tobacco users 1, and e-cigarette users reported the second-highest clinical symptoms of all groups, behind only traditional cigarette smokers. This evidence concerns the gene IGHE and allergic disease.